General Information of the Compound
Compound ID |
CP0040196
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-1H-benzo[d]imidazol-2(3H)-one
Show/Hide
|
||||||||||||||||||
Synonyms |
1-(1-(3-(p-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone
1-(1-(4-(4-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-2H-benzimidazol-2-one
1-(1-(4-(p-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone
1-1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone
1-[1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone
1-[1-[4-(p-F
1-[1-[4-(p-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone
1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one
2-Benzimidazolinone, 1-[1-[3-(p-fluorobenz
3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one
Component of Innovar
DHBP
Dehidrobenzperidol
Dehydrobenzoperidol
Dehydrobenzperidol
Deidrobenzperidolo
Dihidrobenzperidol
Dridol
Dridol (TN)
Droleptan
Droleptan (TN)
Droperidol
Droperidol (JP15/USP/INN)
Droperidol [USAN:INN:BAN:JAN]
Droperidolo
Droperidolo [DCIT]
Droperidolum
Droperidolum [INN-Latin]
Dropletan (TN)
HS-0065
Halkan
INAPSINE (TN)
Ina.psi.n
Ina.psi.ne
Inappin
Inapsin
Inapsine
Inapsine (TN)
Innovan
Innovar-vet
Ino.psi.n
Inopsin
Inoval
Janssen Brand of Droperidol
Kern Brand of Droperidol
Leptanal
Leptofen
Luorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone
McN-JR 4749
McN-JR-4749
Properidol
R 4749
R-4749
R4749
Sintodril
Sintosian
Taylor Brand of Droperidol
Thalamanol
Thalamonal
Vetkalm
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C22H22FN3O2
|
||||||||||||||||||
Molecular Weight |
379.435
|
||||||||||||||||||
Canonical SMILES |
Fc1ccc(cc1)C(=O)CCCN1CCC(=CC1)n1c2ccccc2[nH]c1=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28)
Show/Hide
|
||||||||||||||||||
InChIKey |
RMEDXOLNCUSCGS-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
548-73-2
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2
Cell-based Assay
Clinical Information about the Compound